Michael Pollan and Gul Dolen

The podcast explores the therapeutic potential of psychedelic substances, particularly LSD, psilocybin, and MDMA, focusing on their impact on the brain and their clinical applications. Gul Dolen discusses her research on critical periods for social learning and how psychedelics can reopen these windows, potentially aiding in unlearning harmful associations related to addiction and trauma. Michael Pollan addresses the challenges of integrating psychedelic-assisted psychotherapy into mainstream medicine, including business model issues and regulatory hurdles. The conversation also covers the importance of set and setting in psychedelic experiences, the role of mystical experiences, and the potential for these substances to provide renewed meaning for religious leaders and those facing terminal illnesses.